celecoxib has been researched along with Cardiac Diseases in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The psoriatic arthritis was treated with celecoxib and multiple sclerosis with fingolimod." | 5.38 | A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart? ( Cocco, G, 2012) |
| "The novel cyclooxygenase- (COX)-2 inhibitor celecoxib is an effective treatment for the signs and symptoms of osteoarthritis and rheumatoid arthritis." | 4.80 | Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor. ( Geis, GS; Maurath, CJ; Verburg, KM; Whelton, A, 2000) |
| "The psoriatic arthritis was treated with celecoxib and multiple sclerosis with fingolimod." | 1.38 | A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart? ( Cocco, G, 2012) |
| "In celecoxib-treated zebrafish embryos, the heart failed to undergo normal looping and the heart valve was absent, causing serious blood regurgitation." | 1.37 | Celecoxib impairs heart development via inhibiting cyclooxygenase-2 activity in zebrafish embryos. ( Bu, JW; Du, JL; Gu, SY; Wang, YW; Xia, YM; Xu, DJ, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, DJ | 1 |
| Bu, JW | 1 |
| Gu, SY | 1 |
| Xia, YM | 1 |
| Du, JL | 1 |
| Wang, YW | 1 |
| Cocco, G | 1 |
| Verrico, MM | 1 |
| Weber, RJ | 1 |
| McKaveney, TP | 1 |
| Ansani, NT | 1 |
| Towers, AL | 1 |
| White, WB | 1 |
| Couzin, J | 1 |
| Bogáts, G | 1 |
| Piros, G | 1 |
| Tiszlavicz, L | 1 |
| Iványi, B | 1 |
| Sasi, V | 1 |
| Csepregil, L | 1 |
| Simon, J | 1 |
| Babik, B | 1 |
| Csillik, A | 1 |
| Kardos, L | 1 |
| Palkó, A | 1 |
| Matin, K | 1 |
| Hanzély, Z | 1 |
| Korányi, K | 1 |
| Nyáry, I | 1 |
| Végh, M | 1 |
| Kolozsvári, L | 1 |
| Kahán, Z | 1 |
| Bajcsay, A | 1 |
| Tóth, A | 1 |
| Balázs, G | 1 |
| Simor, T | 1 |
| Pávics, L | 1 |
| Palotás, A | 1 |
| Steffel, J | 1 |
| Akhmedov, A | 1 |
| Fähndrich, C | 1 |
| Ruschitzka, F | 1 |
| Lüscher, TF | 1 |
| Tanner, FC | 1 |
| Whelton, A | 1 |
| Maurath, CJ | 1 |
| Verburg, KM | 1 |
| Geis, GS | 1 |
1 review available for celecoxib and Cardiac Diseases
| Article | Year |
|---|---|
Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor.
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal | 2000 |
7 other studies available for celecoxib and Cardiac Diseases
| Article | Year |
|---|---|
Celecoxib impairs heart development via inhibiting cyclooxygenase-2 activity in zebrafish embryos.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Celecoxib; Cyclooxygenase 2; | 2011 |
A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart?
Topics: Arthritis, Psoriatic; Atrial Fibrillation; Autoimmune Diseases; Celecoxib; Cyclooxygenase Inhibitors | 2012 |
Adverse Drug Events Involving COX-2 Inhibitors.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anti-Inflammatory Agents, N | 2003 |
Hypertension associated with therapies to treat arthritis and pain.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agent | 2004 |
Drug testing. Massive trial of Celebrex seeks to settle safety concerns.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Confounding Factors, Epidemiologic; Cyc | 2005 |
Erdheim-Chester's disease of the heart: a diagnostic conundrum and collision with the same mass in the orbit.
Topics: Celecoxib; Cyclooxygenase 2 Inhibitors; Erdheim-Chester Disease; Heart Diseases; Humans; Male; Middl | 2006 |
Differential effect of celecoxib on tissue factor expression in human endothelial and vascular smooth muscle cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Celecoxib; Cell Line; Endothelium, Vascula | 2006 |